相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes
Jan Petersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self
Fiyaz Mohammed et al.
NATURE IMMUNOLOGY (2008)
Phospho.ELM: a database of phosphorylation sites - update 2008
Francesca Diella et al.
NUCLEIC ACIDS RESEARCH (2008)
A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+T lymphocytes
Pierre Larrieu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Analysis of phosphorylation sites on proteins from Saccharomyces cerevisiae by electron transfer dissociation (ETD) mass spectrometry
An Chi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Melan-A/MART-1-specific CD4 T cells in melanoma patients: Identification of new epitopes specific T cells by MHC class and ex vivo visualization of II Tetramers
Gilles Bioley et al.
JOURNAL OF IMMUNOLOGY (2006)
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks
Jesper V. Olsen et al.
CELL (2006)
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
Angela L. Zarling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles
Emmanuelle Godefroy et al.
CLINICAL IMMUNOLOGY (2006)
Genetic alterations in signaling pathways in melanoma
FG Haluska et al.
CLINICAL CANCER RESEARCH (2006)
Post-translational modifications of naturally processed MHC-binding epitopes
VH Engelhard et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
CD4 T cells in tumor immunity
M Gerloni et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
J Dengjel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes
T Hoashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CD4+ T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation
MS Sharkey et al.
CANCER RESEARCH (2004)
The H4b minor histocompatibility antigen is caused by a combination of genetically determined and posttranslational modifications
R Yadav et al.
JOURNAL OF IMMUNOLOGY (2003)
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy
F Nimmerjahn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/Ipr mice
F Monneaux et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets
JD Lippolis et al.
JOURNAL OF IMMUNOLOGY (2002)
Direct observation of ligand recognition by T cells
DJ Irvine et al.
NATURE (2002)
Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire
VH Engelhard et al.
MOLECULAR IMMUNOLOGY (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
AL Zarling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Melan-A/MART-151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells
HM Zarour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
